Medicare to cover TearLab's test for dry eye disease

10/11/2010 | San Diego Business Journal

TearLab said doctors using its lab-on-a-chip device to diagnose dry eye disease will be reimbursed by the CMS, effective in January 2011. TearLab still is awaiting its clinical laboratory improvement amendments certificate from the FDA for the osmolarity test, which measures eyes' salt concentration. The CLIA waiver is needed to lift some reimbursement restrictions.

View Full Article in:

San Diego Business Journal

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC